SGC-CDKL2/AAK1/BMP2K-1

SGC-CDKL2/AAK1/BMP2K-1 : Inhibitor of CDK2

Structure

Information

  • CDK2
  • Inhibitor
  • up to 1 uM

In Vitro Validations

Uniprot ID: P24941
Target Class: Kinase
Target SubClass: CMGC
Potency: IC50
Potency Value: 230 nM
Potency Assay: In Vitro kinase assay
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Cyclin-dependent kinase 2, CDKN2, CDK2, CDK2_HUMAN ...

DOI Reference: 10.1021/acsmedchemlett.4c00219

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Off Target: AAK1
Potency end-point : IC50 160 nM
Potency assay (off target): SGC-CDKL2/AAK1/BMP2K-1 was profiled in the DiscoverX MAX assay against 403 wild-type kinases at 1 μM. Only 2 kinases showed PoC <10 giving an S10(1 μM) = 0.002. When the PoC <40 fraction was examined, 10 kinases were included (S35(1 μM) = 0.022).
Potency assay, off target (cells): Potential off-targets within the S40(1 μM) fraction were tested via biochemical enzymatic and/or NanoBRET target engagement assays. AAK1: IC50 of 2300 nM; BMP2K: IC50 of 5700 nM in NAnoBRET
Off Target: BMP2K
Potency end-point : IC50 320 nM
I have extra information to add

SERP ratings and comments


SERP+ Ratings

In Cell Rating

SERP+ Comments:

Good in vitro binding affinity & in cells. Comprehensive data in cells with multiple cancer cell lines. Recommended 1 uM for use in cells due to toxicity approaching 10 uM. The compound also shows binding to 2 other related targets AAK1, BMP2K.

(last updated: 23 Sept 2024 )